# Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine

> **NCT01105559** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 455 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Whooping Cough
- Hepatitis B
- Poliomyelitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01105559
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105559, "Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01105559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*